Retrospective Multicenter Observational Study to Evaluate Safety and Effectiveness of Bevacizumab (Avastin®) in Combination With Paclitaxel and Cisplatin/Carboplatin or Toptecan in Patients With Advanced Cervical Cancer
Phase of Trial: Phase IV
Latest Information Update: 06 Oct 2017
At a glance
- Drugs Bevacizumab (Primary) ; Carboplatin; Cisplatin; Paclitaxel; Topotecan
- Indications Cervical cancer
- Focus Adverse reactions
- Sponsors Roche
- 29 Sep 2017 Planned End Date changed from 1 Sep 2017 to 20 Oct 2017.
- 29 Sep 2017 Planned primary completion date changed from 1 Jul 2017 to 20 Oct 2017.
- 29 Sep 2017 Status changed from not yet recruiting to recruiting.